Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Sittings . . . . PDF . . . . Video

Legislative Assembly for the ACT: 2018 Week 05 Hansard (Thursday, 10 May 2018) . . Page.. 1923 ..


Costs

The costs for these activities have been the subject of several Questions on Notice. I refer you to the answer for QoN 178 and QoN 983.

As at 23 March 2018, the costs totalled AUD$410, 150.00 for the delegations to Wellington in support of the sister city engagement. These costs can be broken down by delegations:

July 2016

Signing of the Sister City Agreement

$26,404.00

November 2016

Canberra Week in Wellington

$331,972.00

March 2017

Canberra Week in Wellington

$30,225.00

November 2017

Canberra Week in Wellington

$21,549.00


Health—cancer treatment(Question No 1117)

Mr Coe asked the Minister for Health and Wellbeing, upon notice, on 23 March 2018:

(1) Can the Minister provide a breakdown of the total number of cancer patients treated at ACT Health facilities by cancer type, during (a) 2015-16, (b) 2016-17 and (c) 2017-18 to date.

(2) Can the Minister provide a breakdown of the total number of cancer patients by cancer type that have been required to pay out of pocket cancer costs, during (a) 2015-16, (b) 2016-17 and (c) 2017-18 to date.

(3) Can the Minister provide a breakdown of the average value of out of pocket costs incurred by cancer patients by cancer type, during (a) 2015-16, (b) 2016-17 and (c) 2017-18 to date.

(4) Can the Minister provide a breakdown of the total value of out of pockets costs paid by cancer patients by cancer type, during (a) 2015-16, (b) 2016-17 and (c) 2017-18 to date.

Ms Fitzharris: The answer to the member’s question is as follows:

(1) The total number of cancer patients treated at ACT Health facilities by financial year is:

(a)

2015-16

5,261 patients

(b)

2016-17

5,467 patients

(c)

2017-18 as at 28 February 2018

3,785 patients

Attachment A reflects the breakdown by cancer type.

(2) No. An actual figure is unable to be provided due to the variable treatment pathways and treatment choices made by each individual patient.

(3) No. An actual figure is unable to be provided due to the variable treatment pathways and treatment choices made by each individual patient.


Next page . . . . Previous page . . . . Speeches . . . . Contents . . . . Sittings . . . . PDF . . . . Video